期刊
JOURNAL OF SURGICAL ONCOLOGY
卷 126, 期 5, 页码 865-871出版社
WILEY
DOI: 10.1002/jso.27060
关键词
cancer management; gastric cancer; surgical oncology
资金
- NIH
- NIH/NCI Cancer Center Support Grant [P30 CA008748]
This article summarizes the important changes in gastric cancer management and the supporting data. These changes have been derived from randomized controlled trials, prospective databases, and in-depth analysis of individual patients.
As with every human malignancy, the diagnosis, staging, and treatment of patients with gastric cancer have undergone enormous evidence-based change over the last 50 years, largely as a result of increasingly rapid developments in technology and science. Some of the changes in clinical practice have derived from prospective randomized controlled trials (RCTs), whereas others have come from study of meticulously maintained prospective databases, which define the disease's natural history over time, and occasionally from in-depth analysis of a single patient with an unexpectedly good or poor outcome. Herein we summarize the more important changes in gastric cancer management and the data supporting those changes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据